Therakos Reviews

0 Reviews
0 Reviews

Recommend to a friend
Approve of CEO
(no image)
Ingrid Clark Duffy
0 Ratings

Therakos Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Exton, PA
Size 1 to 5 Employees
Founded Unknown
Type Subsidiary or Business Segment
Industry Manufacturing
Revenue Less than $1 million (USD) per year

Therakos makes the treatment of disease an out-of-body experience. The Johnson & Johnson subsidiary has developed the UVAR XTS and CELLEX photopheresis systems, in which a patient's white blood cells are collected, exposed to ultraviolet light in combination with UVADEX (a light-activated drug), and then returned to the patient. The procedure can be performed on an outpatient basis and is approved in the US, Canada, and Europe to treat skin lesions associated with cutaneous T-cell lymphoma, a kind of cancer of the immune system. Therakos' photopheresis system is the only... More

Work at Therakos? Share Your Experiences


Click to Rate